
LAB
Healthcare · Medical Devices · $279.3M market cap
$0.7074+0.06 (+8.6%)Nov 13, 4:00 PM EST
Next report
Time not confirmed
Analyst consensus
Fiscal period ending Sep 30, 2026
EPS trend, 90 days to now · +42.9% over 90 days · 30-day revisions 0 up, 0 down
Beat estimates in 1 of the last 4 reported quarters.
EPS surprise versus the estimate at the time of the report.
| Date | Session | Estimate | Actual | Surprise |
|---|---|---|---|---|
| Nov 17, 2026 · upcoming | Time not confirmed | -0.01 | -0.06 | -500.0% |
| Aug 5, 2026 | After the close | -0.03 | -0.05 | -66.7% |
| May 5, 2026 | After the close | -0.02 | -0.02 | 0.0% |
| Feb 18, 2026 | Time not confirmed | -0.05 | 0.07 | +226.1% |
| Nov 4, 2025 | After the close | -0.02 | -0.04 | -100.0% |
| Aug 11, 2025 | After the close | -0.04 | -0.04 | 0.0% |
| May 6, 2025 | After the close | -0.04 | -0.05 | -25.0% |
| Feb 26, 2025 | Before the open | -0.03 | -0.05 | -64.7% |
| Oct 30, 2024 | After the close | -0.07 | -0.03 | +57.1% |
| Jul 31, 2024 | After the close | -0.07 | -0.08 | -14.3% |
| May 8, 2024 | After the close | -0.10 | -0.24 | -140.0% |
| Feb 28, 2024 | After the close | -0.13 | -0.25 | -92.3% |
| Nov 7, 2023 | After the close | -0.12 |
Standard BioTools Inc., together with its subsidiaries, develops, manufactures, and sells a range of instrumentation, consumables, and services to scientists and biomedical researchers to develop therapeutics in the Americas, Europe, the Middle East, Africa, and the Asia pacific. The company operates through Proteomics and Genomics segments. Its proteomics and genomics include instruments, consumables, and assays…
| -0.14 |
| -16.7% |
| Aug 8, 2023 | After the close | -0.10 | -0.14 | -40.0% |
| May 9, 2023 | After the close | -0.06 | -0.21 | -250.0% |
| Feb 14, 2023 | After the close | -0.28 | -0.26 | +7.1% |
| Nov 8, 2022 | After the close | -0.13 | -0.37 | -184.6% |
| Aug 8, 2022 | After the close | -0.15 | -0.33 | -120.0% |
| May 5, 2022 | After the close | -0.18 | -0.25 | -38.9% |
| Feb 17, 2022 | After the close | -0.28 | -0.12 | +57.1% |
| Nov 8, 2021 | After the close | -0.11 | -0.07 | +36.4% |
| Aug 5, 2021 | After the close | -0.08 | -0.12 | -50.0% |
| May 6, 2021 | After the close | -0.04 | -0.15 | -275.0% |
| Feb 10, 2021 | After the close | 0.01 | -0.13 | -1400.0% |
| Nov 5, 2020 | After the close | -0.11 | 0.03 | +127.3% |
| Aug 6, 2020 | After the close | -0.14 | -0.07 | +50.0% |
| May 7, 2020 | After the close | -0.10 | -0.13 | -30.0% |
| Feb 10, 2020 | After the close | -0.09 | -0.03 | +66.7% |
| Nov 5, 2019 | After the close | -0.09 | -0.09 | 0.0% |
| Aug 1, 2019 | After the close | -0.07 | -0.10 | -42.9% |
| May 2, 2019 | After the close | -0.10 | -0.14 | -40.0% |
| Feb 7, 2019 | After the close | -0.19 | -0.06 | +68.4% |
| Nov 1, 2018 | After the close | -0.18 | -0.13 | +27.8% |
| Aug 2, 2018 | After the close | -0.23 | -0.23 | 0.0% |
| May 3, 2018 | After the close | -0.30 | -0.21 | +30.0% |
| Feb 8, 2018 | After the close | -0.25 | -0.15 | +40.0% |